OA
LH icon

Operose Advisors’s Labcorp LH Stock Holding History

Operose Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34
Closed -$7.6K – 547
2024
Q3 		$7.6K Hold
34
– – ﹤0.01% 522
2024
Q2 		$6.92K Hold
34
– – ﹤0.01% 480
2024
Q1 		$7.43K Hold
34
– – ﹤0.01% 513
2023
Q4 		$7.73K Hold
34
– – ﹤0.01% 492
2023
Q3 		$6.84K Buy
+34
New +$7.17K ﹤0.01% 627

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Operose Advisors's LH Position: Q4 2024 in Review

Operose Advisors sold out of Labcorp (LH) in Q4 2024, closing a stake of 34 shares — an estimated $7.6K sold.

Operose Advisors first reported a position in LH in Q3 2023 and held it in 5 quarters. The position peaked at $7.73K in Q4 2023. 927 funds tracked by Wall St. Rank hold LH as of Q4 2024.

  • Operose Advisors reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 34 Labcorp shares in Q4 2024, an estimated $7.6K.
  • Operose Advisors first reported a position in Labcorp in Q3 2023 and held it in 5 quarters.
  • Operose Advisors's Labcorp position peaked at $7.73K in Q4 2023.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.